LMWH - New mechanisms of action

Thrombosis Research

Volumn 123, Issue SUPPL. 3, 2009, Pages

  Harenberg, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; GLYCOSAMINOGLYCAN; HEPARIN; HEPARIN DERIVATIVE; IDRAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; PI 88; TINZAPARIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOCHEMISTRY; CARBOHYDRATE SYNTHESIS; CLINICAL TRIAL; DEPOLYMERIZATION; DRUG MECHANISM; ENZYME SYNTHESIS; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; INFLAMMATION; LIVER CELL CARCINOMA; MEDICAL TECHNOLOGY; METASTASIS INHIBITION; MICROARRAY ANALYSIS; MICROFLUIDIC ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; STRUCTURE ANALYSIS; THROMBOSIS;

EID: 59449088169     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(09)70125-2     Document Type: Article

References (12)

1. Harenberg J., and Casu B. Preface. Semin Thromb Hemost 33 (2007) 449-453
2. Linhardt R.J., Dordick J.S., Deangelis P.L., and Liu J. Enzymatic synthesis of glycosaminoglycan heparin. Semin Thromb Hemost 33 (2007) 453-465
3. Vismara E., Pierini M., Guglieri S., Liverani L., Mascellani G., and Torri G. Structural modification induced in heparin by a Fenton-type depolymerization process. Semin Thromb Hemost 33 (2007) 466-477
4. Guerrini M., Guglieri S., Naggi A., Sasisekharan R., and Torri G. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin Thromb Hemost 33 (2007) 478-487
5. Bianchini P., Liverani L., Spelta F., Mascellani G., and Parma B. Variability of heparins and heterogeneity of low molecular weight heparins. Semin Thromb Hemost 33 (2007) 496-502
6. Harenberg J., Giese C., Hagedorn A., Traeger I., and Fenyvesi T. Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time. Semin Thromb Hemost 33 (2007) 503-507
7. Nowak G., Lange U., Wiesenburg A., and Bucha E. Measurement of maximum thrombin generation capacity in blood and plasma using the thrombin generation assay (THROGA). Semin Thromb Hemost 33 (2007) 508-514
8. Mousa S.A. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links. Semin Thromb Hemost 33 (2007) 524-533
9. Simonis D., Christ K., Alban S., and Bendas G. Affinity and kinetics of different heparins binding to P- and L-selectin. Semin Thromb Hemost 33 (2007) 534-539
10. Borsig L. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis. Semin Thromb Hemost 33 (2007) 540-546
11. Borgenstr̈om M., Ẅarri A., Hiilesvuo K., K̈ak̈onen R., K̈ak̈onen S., Nissinen L., et al. O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis. Semin Thromb Hemost 33 (2007) 547-556
12. Ferro V., Dredge K., Liu L., Hammond E., Bytheway I., Li C., et al. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Semin Thromb Hemost 33 (2007) 557-568